23andMe Investor Day Presentation Deck
Health Predispositions
30+
Including:
Type 2 Diabetes (Powered by 23andMe Research)
Coronary Artery Disease 23andMe+
Uterine Fibroids
Migraine 23andMe+
MUTYH-Associated Polyposis
BRCA1/BRCA2 (selected variants)
HOXB13 (prostate cancer)
Type 2 Diabetes
Your genetics
are associated
with a typical
likelihood.
Based on your:
DOC
Genetics
Age
Our Health Service
The First and Only Multi-Disease DTC Genetic Service That Includes FDA-Authorized Reports
and Provides Personalized Genetic Insights and Tools
37%
(4)
Ethnicity
1 Wellness information does not require FDA Authorization.
Wellness 1
10
Including:
Muscle Composition
Genetic Weight
Alcohol Flush Reaction
Saturated Fat and Weight
Sleep Movement
Dog & Cat Allergies 23andMe+
Genetic Weight
YOUR RESULT
Your genes
predispose you to
weigh about 7%
less than average.
Average
142
lbs
Carrier Status
40+
Including:
Cystic Fibrosis
Sickle Cell Anemia
Familial Hyperinsulinism (ABCC8-Related)
Tay-Sachs Disease
Glycogen Storage Disease (Type 1a)
Chromosome 15
Tay-Sachs Disease
YOUR RESULT
You do not have
the variants we
tested.
0
variants detected
in the HEXA gene
Pharmacogenetics
3
Including:
SLC01B1 Drug Transport
CYP2C19 Drug Metabolism
• e.g., citalopram and clopidogrel
DPYD Drug Metabolism
Pharmacogenetics
Genetic variants may
influence how you
process medications.
YOUR RESULTS
CYP2C19 Drug
Metabolism
LIKELY NORMAL METABOLIZER
DPYD Drug
Metabolism
LIKELY NORMAL METABOLIZER
SLCO1B1 Drug
Transport
LIKELY NORMAL METABOLIZER
Print summary
7 FDA
Authorizations
Copyright © 2022 23and Me, Inc.
23andMe+
23andMeⓇ
62View entire presentation